CMS von Erlach Partners Ltd. houses a broad offering which notably acts for Bayer, Eli Lilly, and Unilabs, often leveraging its international network of offices. The team also handles advertising-focused proceedings and cross-border acquisitions. Team co-leads Patrick Sommer routinely advises on M&A and administrative proceedings concerning antitrust pricing issues, and Christoph Willi is well-equipped to handle series financing matters and patent portfolio management mandates.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Oversight, diligence, excellent business acumen.’
‘International network which allows quick access to lawyers based in other jurisdictions.’
‘Very skilled people, highly reactive and to the point.’
'Christoph Willi: Fast response times, puts the customer at the centre.'
Kernmandanten
- Bayer (Switzerland) AG
- Syncona Ltd
- Medbase AG
- Unilabs AG
- Vista Klinik Holding AG
- Eli Lilly (Suisse) S.A
- Lilly Deutschland GmbH
- Ypsomed AG
Highlight-Mandate
- Advised Vista Klinik Holding AG on the acquisition of ophthalmological service providers and related regulatory questions.
- Advised Ypsomed AG on the sale of its pen needle and blood glucose monitoring system business with reported sales of CHF 52 million in 2022/2023.
- Acted in arbitration proceedings for a Swiss-American pharmaceutical manufacturer against a clinical developer concerning an innovative drug candidate for the treatment of haematological malignancies.
Anwält*innen
Praxisleitung
Patrick Sommer; Christoph Willi
Weitere Kernanwält*innen
Alain Raemy; Simone Brauchbar Birkhäuser; Julia Haas